Real Estate & Construction » Real Estate | HH Biotechnology Holdings Co.

HH Biotechnology Holdings Co. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Other Funds
-
1,426.60
2,952.50
-
6,217.00
Funds from Operations
1,574.10
985.40
1,616.80
1,733.40
3,411.40
Changes in Working Capital
14.70
219.80
76.00
47.70
162.00
Net Operating Cash Flow
1,588.80
765.60
1,692.80
1,685.80
3,573.50
Capital Expenditures
1.00
12.10
17.00
0.60
41.90
Net Investing Cash Flow
5,133.00
12.10
17.00
0.60
41.90
Issuance/Reduction of Debt, Net
-
317.00
2,326.20
162.30
16,228.10
Net Financing Cash Flow
-
1,109.60
626.30
162.30
2,467.00
Net Change in Cash
3,289.60
366.90
1,187.90
1,683.80
1,020.00
Free Cash Flow
1,587.80
753.50
1,675.80
1,685.10
3,531.60
Change in Capital Stock
-
-
-
-
7,544.00
Exchange Rate Effect
254.60
10.80
138.40
163.70
44.50
Other Uses
5,132.00
-
-
-
-

About HH Biotechnology Holdings

View Profile
Address
C Site, 25-26F President Building
Shenyang Liaoning 110003
China
Employees -
Website http://www.greatchinaholdings.com
Updated 07/08/2019
HH Biotechnology Holdings Co. through its various subsidiaries, is engaged in the commercial and residential real estate leasing, management, consulting, investment, development and sales in the city of Shenyang, Liaoning Province, in the People' Republic of China. The company operates its business through the following segments: Property for sale, and Rental income and Income of management fee of commercial buildings. The company was founded on December 4, 1987 and is headquartered in Shenyang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.